Topics

STAT Plus: FDA considers a rating system for manufacturing facilities as a way to fight drug shortages

12:42 EDT 28 Oct 2019 | STAT

“Unfortunately, incentives today are not high enough for many manufacturers to establish mature quality management capabilities," said FDA's Janet Woodcock.

Original Article: STAT Plus: FDA considers a rating system for manufacturing facilities as a way to fight drug shortages

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: FDA considers a rating system for manufacturing facilities as a way to fight drug shortages"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...